Cargando…

The clinical features and estimated incidence of MIS-C in Cape Town, South Africa

BACKGROUND: Multisystem inflammatory syndrome is a severe manifestation of SARS-CoV-2 in children. The incidence of MIS-C after infection is poorly understood. There are very few cohorts describing MIS-C in Africa despite MIS-C being more common in Black children worldwide. METHODS: A cohort of chil...

Descripción completa

Detalles Bibliográficos
Autores principales: Butters, Claire, Abraham, Deepthi Raju, Stander, Raphaella, Facey-Thomas, Heidi, Abrahams, Debbie, Faleye, Ayodele, Allie, Nazneen, Soni, Khushbu, Rabie, Helena, Scott, Christiaan, Zühlke, Liesl, Webb, Kate
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059902/
https://www.ncbi.nlm.nih.gov/pubmed/35501710
http://dx.doi.org/10.1186/s12887-022-03308-z
_version_ 1784698403199909888
author Butters, Claire
Abraham, Deepthi Raju
Stander, Raphaella
Facey-Thomas, Heidi
Abrahams, Debbie
Faleye, Ayodele
Allie, Nazneen
Soni, Khushbu
Rabie, Helena
Scott, Christiaan
Zühlke, Liesl
Webb, Kate
author_facet Butters, Claire
Abraham, Deepthi Raju
Stander, Raphaella
Facey-Thomas, Heidi
Abrahams, Debbie
Faleye, Ayodele
Allie, Nazneen
Soni, Khushbu
Rabie, Helena
Scott, Christiaan
Zühlke, Liesl
Webb, Kate
author_sort Butters, Claire
collection PubMed
description BACKGROUND: Multisystem inflammatory syndrome is a severe manifestation of SARS-CoV-2 in children. The incidence of MIS-C after infection is poorly understood. There are very few cohorts describing MIS-C in Africa despite MIS-C being more common in Black children worldwide. METHODS: A cohort of children with MIS-C and healthy children was recruited from May 2020 until May 2021 from the two main paediatric hospitals in Cape Town, South Africa. Clinical and demographic data were collected, and serum was tested for SARS-CoV-2 antibodies. The incidence of MIS-C was calculated using an estimation of population exposure from seroprevalence in the healthy group. Summary data, non-parametric comparisons and logistic regression analyses were performed. RESULTS: Sixty eight children with MIS-C were recruited with a median age of 7 years (3.6, 9.9). Ninety seven healthy children were recruited with a 30% seroprevalence. The estimated incidence of MIS-C was 22/100 000 exposures in the city in this time. Black children were over-represented in the MIS-C group (62% vs 37%, p = 0.002). The most common clinical features in MIS-C were fever (100%), tachycardia (98.5%), rash (85.3%), conjunctivitis (77.9%), abdominal pain (60.3%) and hypotension (60.3%). The median haemoglobin, sodium, neutrophil count, white cell count, CRP, ferritin, cardiac (pro-BNP, trop-T) and coagulation markers (D-dimer and fibrinogen) were markedly deranged in MIS-C. Cardiac, pulmonary, central nervous and renal organ systems were involved in 71%, 29.4%, 27.9% and 27.9% respectively. Ninety four percent received intravenous immune globulin, 64.7% received methylprednisolone and 61.7% received both. Forty percent required ICU admission, 38.2% required inotropic support, 38.2% required oxygen therapy, 11.8% required invasive ventilation and 6% required peritoneal dialysis. Older age was an independent predictor for the requirement for ionotropic support (OR = 1.523, CI 1.074, 2.16, p = 0.018). The median hospital stay duration was 7 days with no deaths. CONCLUSION: The lack of reports from Southern Africa does not reflect a lack of cases of MIS-C. MIS-C poses a significant burden to children in the region as long as the pandemic continues. MIS-C disproportionately affects black children. The clinical manifestations and outcomes of MIS-C in this region highlight the need for improved surveillance, reporting and data to inform diagnosis and treatment. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12887-022-03308-z.
format Online
Article
Text
id pubmed-9059902
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-90599022022-05-03 The clinical features and estimated incidence of MIS-C in Cape Town, South Africa Butters, Claire Abraham, Deepthi Raju Stander, Raphaella Facey-Thomas, Heidi Abrahams, Debbie Faleye, Ayodele Allie, Nazneen Soni, Khushbu Rabie, Helena Scott, Christiaan Zühlke, Liesl Webb, Kate BMC Pediatr Research BACKGROUND: Multisystem inflammatory syndrome is a severe manifestation of SARS-CoV-2 in children. The incidence of MIS-C after infection is poorly understood. There are very few cohorts describing MIS-C in Africa despite MIS-C being more common in Black children worldwide. METHODS: A cohort of children with MIS-C and healthy children was recruited from May 2020 until May 2021 from the two main paediatric hospitals in Cape Town, South Africa. Clinical and demographic data were collected, and serum was tested for SARS-CoV-2 antibodies. The incidence of MIS-C was calculated using an estimation of population exposure from seroprevalence in the healthy group. Summary data, non-parametric comparisons and logistic regression analyses were performed. RESULTS: Sixty eight children with MIS-C were recruited with a median age of 7 years (3.6, 9.9). Ninety seven healthy children were recruited with a 30% seroprevalence. The estimated incidence of MIS-C was 22/100 000 exposures in the city in this time. Black children were over-represented in the MIS-C group (62% vs 37%, p = 0.002). The most common clinical features in MIS-C were fever (100%), tachycardia (98.5%), rash (85.3%), conjunctivitis (77.9%), abdominal pain (60.3%) and hypotension (60.3%). The median haemoglobin, sodium, neutrophil count, white cell count, CRP, ferritin, cardiac (pro-BNP, trop-T) and coagulation markers (D-dimer and fibrinogen) were markedly deranged in MIS-C. Cardiac, pulmonary, central nervous and renal organ systems were involved in 71%, 29.4%, 27.9% and 27.9% respectively. Ninety four percent received intravenous immune globulin, 64.7% received methylprednisolone and 61.7% received both. Forty percent required ICU admission, 38.2% required inotropic support, 38.2% required oxygen therapy, 11.8% required invasive ventilation and 6% required peritoneal dialysis. Older age was an independent predictor for the requirement for ionotropic support (OR = 1.523, CI 1.074, 2.16, p = 0.018). The median hospital stay duration was 7 days with no deaths. CONCLUSION: The lack of reports from Southern Africa does not reflect a lack of cases of MIS-C. MIS-C poses a significant burden to children in the region as long as the pandemic continues. MIS-C disproportionately affects black children. The clinical manifestations and outcomes of MIS-C in this region highlight the need for improved surveillance, reporting and data to inform diagnosis and treatment. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12887-022-03308-z. BioMed Central 2022-05-02 /pmc/articles/PMC9059902/ /pubmed/35501710 http://dx.doi.org/10.1186/s12887-022-03308-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Butters, Claire
Abraham, Deepthi Raju
Stander, Raphaella
Facey-Thomas, Heidi
Abrahams, Debbie
Faleye, Ayodele
Allie, Nazneen
Soni, Khushbu
Rabie, Helena
Scott, Christiaan
Zühlke, Liesl
Webb, Kate
The clinical features and estimated incidence of MIS-C in Cape Town, South Africa
title The clinical features and estimated incidence of MIS-C in Cape Town, South Africa
title_full The clinical features and estimated incidence of MIS-C in Cape Town, South Africa
title_fullStr The clinical features and estimated incidence of MIS-C in Cape Town, South Africa
title_full_unstemmed The clinical features and estimated incidence of MIS-C in Cape Town, South Africa
title_short The clinical features and estimated incidence of MIS-C in Cape Town, South Africa
title_sort clinical features and estimated incidence of mis-c in cape town, south africa
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059902/
https://www.ncbi.nlm.nih.gov/pubmed/35501710
http://dx.doi.org/10.1186/s12887-022-03308-z
work_keys_str_mv AT buttersclaire theclinicalfeaturesandestimatedincidenceofmiscincapetownsouthafrica
AT abrahamdeepthiraju theclinicalfeaturesandestimatedincidenceofmiscincapetownsouthafrica
AT standerraphaella theclinicalfeaturesandestimatedincidenceofmiscincapetownsouthafrica
AT faceythomasheidi theclinicalfeaturesandestimatedincidenceofmiscincapetownsouthafrica
AT abrahamsdebbie theclinicalfeaturesandestimatedincidenceofmiscincapetownsouthafrica
AT faleyeayodele theclinicalfeaturesandestimatedincidenceofmiscincapetownsouthafrica
AT allienazneen theclinicalfeaturesandestimatedincidenceofmiscincapetownsouthafrica
AT sonikhushbu theclinicalfeaturesandestimatedincidenceofmiscincapetownsouthafrica
AT rabiehelena theclinicalfeaturesandestimatedincidenceofmiscincapetownsouthafrica
AT scottchristiaan theclinicalfeaturesandestimatedincidenceofmiscincapetownsouthafrica
AT zuhlkeliesl theclinicalfeaturesandestimatedincidenceofmiscincapetownsouthafrica
AT webbkate theclinicalfeaturesandestimatedincidenceofmiscincapetownsouthafrica
AT buttersclaire clinicalfeaturesandestimatedincidenceofmiscincapetownsouthafrica
AT abrahamdeepthiraju clinicalfeaturesandestimatedincidenceofmiscincapetownsouthafrica
AT standerraphaella clinicalfeaturesandestimatedincidenceofmiscincapetownsouthafrica
AT faceythomasheidi clinicalfeaturesandestimatedincidenceofmiscincapetownsouthafrica
AT abrahamsdebbie clinicalfeaturesandestimatedincidenceofmiscincapetownsouthafrica
AT faleyeayodele clinicalfeaturesandestimatedincidenceofmiscincapetownsouthafrica
AT allienazneen clinicalfeaturesandestimatedincidenceofmiscincapetownsouthafrica
AT sonikhushbu clinicalfeaturesandestimatedincidenceofmiscincapetownsouthafrica
AT rabiehelena clinicalfeaturesandestimatedincidenceofmiscincapetownsouthafrica
AT scottchristiaan clinicalfeaturesandestimatedincidenceofmiscincapetownsouthafrica
AT zuhlkeliesl clinicalfeaturesandestimatedincidenceofmiscincapetownsouthafrica
AT webbkate clinicalfeaturesandestimatedincidenceofmiscincapetownsouthafrica